These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 7822308

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
    ten Dijke P, Yamashita H, Sampath TK, Reddi AH, Estevez M, Riddle DL, Ichijo H, Heldin CH, Miyazono K.
    J Biol Chem; 1994 Jun 24; 269(25):16985-8. PubMed ID: 8006002
    [Abstract] [Full Text] [Related]

  • 23. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling.
    Lewis KA, Gray PC, Blount AL, MacConell LA, Wiater E, Bilezikjian LM, Vale W.
    Nature; 2000 Mar 23; 404(6776):411-4. PubMed ID: 10746731
    [Abstract] [Full Text] [Related]

  • 24. Monomeric activin A retains high receptor binding affinity but exhibits low biological activity.
    Hüsken-Hindi P, Tsuchida K, Park M, Corrigan AZ, Vaughan JM, Vale WW, Fischer WH.
    J Biol Chem; 1994 Jul 29; 269(30):19380-4. PubMed ID: 8034704
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of vascular endothelial cell growth by activin-A.
    McCarthy SA, Bicknell R.
    J Biol Chem; 1993 Nov 05; 268(31):23066-71. PubMed ID: 8226823
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Inhibin antagonizes inhibition of liver cell growth by activin by a dominant-negative mechanism.
    Xu J, McKeehan K, Matsuzaki K, McKeehan WL.
    J Biol Chem; 1995 Mar 17; 270(11):6308-13. PubMed ID: 7890768
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.
    Feng XH, Derynck R.
    EMBO J; 1997 Jul 01; 16(13):3912-23. PubMed ID: 9233801
    [Abstract] [Full Text] [Related]

  • 30. Inactivation of activin-dependent transcription by kinase-deficient activin receptors.
    Tsuchida K, Vaughan JM, Wiater E, Gaddy-Kurten D, Vale WW.
    Endocrinology; 1995 Dec 01; 136(12):5493-503. PubMed ID: 7588300
    [Abstract] [Full Text] [Related]

  • 31. A widely expressed transmembrane serine/threonine kinase that does not bind activin, inhibin, transforming growth factor beta, or bone morphogenic factor.
    Matsuzaki K, Xu J, Wang F, McKeehan WL, Krummen L, Kan M.
    J Biol Chem; 1993 Jun 15; 268(17):12719-23. PubMed ID: 8389764
    [Abstract] [Full Text] [Related]

  • 32. Distinct localization of two serine-threonine kinase receptors for activin and TGF-beta in the rat brain and down-regulation of type I activin receptor during peripheral nerve regeneration.
    Morita N, Takumi T, Kiyama H.
    Brain Res Mol Brain Res; 1996 Dec 15; 42(2):263-71. PubMed ID: 9013782
    [Abstract] [Full Text] [Related]

  • 33. Identification of a functional binding site for activin on the type I receptor ALK4.
    Harrison CA, Gray PC, Koerber SC, Fischer W, Vale W.
    J Biol Chem; 2003 Jun 06; 278(23):21129-35. PubMed ID: 12665502
    [Abstract] [Full Text] [Related]

  • 34. Two distinct transmembrane serine/threonine kinases from Drosophila melanogaster form an activin receptor complex.
    Wrana JL, Tran H, Attisano L, Arora K, Childs SR, Massagué J, O'Connor MB.
    Mol Cell Biol; 1994 Feb 06; 14(2):944-50. PubMed ID: 8289834
    [Abstract] [Full Text] [Related]

  • 35. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
    Lebrun JJ, Vale WW.
    Mol Cell Biol; 1997 Mar 06; 17(3):1682-91. PubMed ID: 9032295
    [Abstract] [Full Text] [Related]

  • 36. Cloning of a novel type II serine/threonine kinase receptor through interaction with the type I transforming growth factor-beta receptor.
    Kawabata M, Chytil A, Moses HL.
    J Biol Chem; 1995 Mar 10; 270(10):5625-30. PubMed ID: 7890683
    [Abstract] [Full Text] [Related]

  • 37. Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling.
    Zhou Y, Sun H, Danila DC, Johnson SR, Sigai DP, Zhang X, Klibanski A.
    Mol Endocrinol; 2000 Dec 10; 14(12):2066-75. PubMed ID: 11117535
    [Abstract] [Full Text] [Related]

  • 38. Endoglin is an accessory protein that interacts with the signaling receptor complex of multiple members of the transforming growth factor-beta superfamily.
    Barbara NP, Wrana JL, Letarte M.
    J Biol Chem; 1999 Jan 08; 274(2):584-94. PubMed ID: 9872992
    [Abstract] [Full Text] [Related]

  • 39. Function of the type V transforming growth factor beta receptor in transforming growth factor beta-induced growth inhibition of mink lung epithelial cells.
    Liu Q, Huang SS, Huang JS.
    J Biol Chem; 1997 Jul 25; 272(30):18891-5. PubMed ID: 9228067
    [Abstract] [Full Text] [Related]

  • 40. Serine/threonine kinase receptors.
    ten Dijke P, Franzén P, Yamashita H, Ichijo H, Heldin CH, Miyazono K.
    Prog Growth Factor Res; 1994 Jul 25; 5(1):55-72. PubMed ID: 8199354
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.